VivoPath is a preclinical screening company, offering our clients discovery and development services for in vivo testing.
VivoPath provides integrated in vivo studies led by established experts in drug development. Efficacy is established for animal models in the areas of metabolic disease, inflammation, neurodegenerative disease, and infectious diseases. Formulation screening is carried out to select the most appropriate delivery system for administration. Pharmacokinetic evaluation is carried out to assess exposure and bioavailability. Tolerability is assessed with evaluations of clinical signs, clinical chemistry and hematology. The resulting comprehensive program delivers the client an in vivo therapeutic index (TI) report on which to assess candidates for subsequent development. VivoPath can also help clients at any individual step in this preclinical screening process.
VivoPath’s commitment is to provide scientific expertise in in vivo drug discovery in order to increase productivity from research into drug development.